Wall Street Analysts Believe Prestige Consumer Healthcare (PBH) Could Rally 26.06%: Here's is How to Trade

The consensus price target hints at a 26.1% upside potential for Prestige Consumer Healthcare (PBH). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Zacks Investment Research • Dec 8, 2025

PBH or ABT: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Abbott (ABT). But which of these two stocks is more attractive to value investors?

Zacks Investment Research • Dec 1, 2025

Premium Brands Holdings Corporation (PBH:CA) Q3 2025 Earnings Call Transcript

Premium Brands Holdings Corporation ( PBH:CA ) Q3 2025 Earnings Call November 10, 2025 1:30 PM EST Company Participants George Paleologou - President, CEO & Director Will Kalutycz - Chief Financial Officer Conference Call Participants Christopher Li - Desjardins Securities Inc., Research Division Martin Landry - Stifel Nicolaus Canada Inc., Research Division Kyle McPhee - Cormark Securities Inc., Research Division Derek Lessard - TD Cowen, Research Division Luke Hannan - Canaccord Genuity Corp., Research Division Michael Glen - Raymond James Ltd., Research Division Stephen MacLeod - BMO Capital Markets Equity Research Ty Collin - CIBC Capital Markets, Research Division Vishal Shreedhar - National Bank Financial, Inc., Research Division John Zamparo - Scotiabank Global Banking and Markets, Research Division Ryland Conrad - RBC Capital Markets, Research Division Presentation George Paleologou President, CEO & Director Good morning, and welcome, everyone, to our 2025 Third Quarter Conference Call.

Seeking Alpha • Nov 10, 2025

Prestige Consumer Healthcare Inc. (PBH) Q2 2026 Earnings Call Transcript

Prestige Consumer Healthcare Inc. ( PBH ) Q2 2026 Earnings Call November 6, 2025 8:30 AM EST Company Participants Philip Terpolilli - Director of Investor Relations Ron Lombardi - Chairman, President & CEO Christine Sacco - CFO & COO Conference Call Participants Susan Anderson - Canaccord Genuity Corp., Research Division Rupesh Parikh - Oppenheimer & Co. Inc., Research Division Keith Devas - Jefferies LLC, Research Division Jon Andersen - William Blair & Company L.L.C., Research Division Mitchell Pinheiro - Sturdivant & Co., Inc., Research Division Anthony Lebiedzinski - Sidoti & Company, LLC Douglas Lane - Water Tower Research LLC Presentation Operator Good day, and thank you for standing by.

Seeking Alpha • Nov 6, 2025

Prestige Consumer Healthcare Inc. Reports Second Quarter and First Half Fiscal 2026 Results

TARRYTOWN, N.Y., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its second quarter and first six months ended September 30, 2025.

GlobeNewsWire • Nov 6, 2025

Prestige Consumer Healthcare (PBH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Prestige Consumer Healthcare (PBH) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Investment Research • Nov 6, 2025

Prestige Consumer Healthcare (PBH) Beats Q2 Earnings and Revenue Estimates

Prestige Consumer Healthcare (PBH) came out with quarterly earnings of $1.07 per share, beating the Zacks Consensus Estimate of $0.97 per share. This compares to earnings of $1.09 per share a year ago.

Zacks Investment Research • Nov 6, 2025

Earnings Preview: Prestige Consumer Healthcare (PBH) Q2 Earnings Expected to Decline

Prestige Consumer Healthcare (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research • Oct 30, 2025

Q3 2025 Improving Fundamentals Position Portfolio For Upside

The Value Plus Strategy gained 8.50% in the third quarter, compared with the 12.60% gain for the Russell 2000® Value Index. Brady's core business is identification solutions for commercial products, allowing clients to trace and track parts. Materion has been taking several steps to improve operations and bolster margins during a slower overall period for some of its end markets, such as autos, industrials, and life sciences.

Seeking Alpha • Oct 29, 2025

Prestige Consumer Healthcare to Release Fiscal 2026 Second Quarter Earnings Results

TARRYTOWN, N.Y., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2026 second quarter and first half earnings release on Thursday, November 6, 2025 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.

GlobeNewsWire • Oct 6, 2025